Table 2.
Risk factors for GIB after haplo-HSCT.
| Variables | Univariate P value | Multivariate | ||
|---|---|---|---|---|
| HR | 95% | P value | ||
| Age > 30 | 0.004 | 1.069 | 0.786–1.454 | 0.670 |
| Male | 0.212 | |||
| ABO mismatch | 0.147 | |||
| Donor-recipient sex mismatch | 0.199 | |||
| SOS | 0.038 | 6.105 | 1.471–25.341 | 0.013 |
| DIC | 0.097 | 1.301 | 0.633–2.675 | 0.474 |
| AKI | 0.000 | 3.115 | 2.110–4.599 | 0.000 |
| CMV viremia | 0.148 | |||
| Platelet counts < 30 × 109/L | 0.000 | 2.408 | 1.785–3.248 | 0.000 |
| Viral hepatitis | 0.000 | 1.965 | 1.244–3.102 | 0.004 |
| Gastrointestinal disease or bleeding before HSCT | 0.000 | 3.780 | 2.334–6.122 | 0.000 |
| Diabetes mellitus | 0.153 | |||
| Alcohol | 0.092 | 1.384 | 0.605–3.168 | 0.441 |
GIB gastrointestinal bleeding, SOS sinusoidal obstruction syndrome, DIC disseminated intravascular coagulation, AKI acute kidney injury, CMV cytomegalovirus, HSCT haematopoietic stem cell transplantation.